Interferon autoantibodies not implicated in long-COVID

Research scientist using digital tablet to browse internet and find biochemistry discovery. Female chemist working with device to create pharmaceutical cure, microbiology experiment.

Researchers assess the proportion of interferon autoantibodies in long COVID patients.

Cedars-Sinai and Huntington Health collaborate to bring epilepsy care closer to patients

Previous article

Yale scientists seek to identify optimal sequential treatments for advanced cancer

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News